Business & Regulation

Industry collaboration can only result in better treatments for lung cancer.

Craig Burton from the AAM says patients must be able to access generics and biosimilars.

How can the FDA tackle the inspection backlog?

We sit down with Jason Lacombe, CEO of Veratrak, to find out more about blockchain for pharma.

Sputnik V (finally and definitely) starts rolling review with the EMA.

If you could expand into a new therapeutic space, should you? And what’s the right path forward, if you make the leap?

How to add value and reduce risks with ethics.

Women in pharma choose to challenge the status quo through their contributions. This International Women's Day we celebrate them.

Experts from our previous Power Lists discuss the challenges of leadership during these trying times.

What role have small molecules played in the fight against COVID-19?